p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients

Journal of Cellular Physiology

Volumn 206, Issue 3, 2006, Pages 611-615

  Ulivi, Paola ^a   Zoli, Wainer ^a   Calistri, Daniele ^a   Fabbri, Francesco ^a   Tesei, Anna ^a   Rosetti, Marco ^a   Mengozzi, Marta ^a   Amadori, Dino ^b  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN CDH13; PROTEIN P16INK4A; UNCLASSIFIED DRUG; CADHERIN; H CADHERIN; H-CADHERIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CDH13 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERMETHYLATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; NON INVASIVE PROCEDURE; P16INK4A GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; TUMOR SUPPRESSOR GENE; BLOOD; DNA METHYLATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); TUMOR MARKERS, BIOLOGICAL;

EID: 31944448123     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20503     Document Type: Article

References (32)

1. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, Sidransky D. 1999. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91:332-339.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. 1998. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141-196.
3. INK4A hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res 8:3782-3787.
4. Belinsky SA. 2004. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707-717.
5. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896.
6. Christofori G. 2003. Changing neighbours, changing behaviour: Cell adhesion molecule-mediated signalling during tumour progression. EMBO J 22:2318-2323.
7. INK4A alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers. Lung Cancer 44:23-32.
8. Diederich S, Wormanns D. 2004. Impact of low-dose CT on lung cancer screening. Lung Cancer 45(Suppl 2):S13-S19.
9. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. 1999. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67-70.
10. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
11. Forgacs E, Zochbauer-Muller S, Olah E, Minna JD. 2001. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 7: 6-13.
12. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M. 2005. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 11:1219-1225.
13. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C. 2005. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 47:9-15.
14. Hanabata T, Tsukuda K, Toyooka S, Yano M, Aoe M, Nagahiro I, Sano Y, Date H, Shimizu N. 2004. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers. Oncol Rep 12:177-180.
15. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D. 2003. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 9:1370-1375.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
17. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA, Jr. 2001. Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7:5-22.
18. INK4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 18:3221-3229.
19. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH. 2004. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 22:2363-2370.
20. INK4a in Chinese lung cancer patients: Biological and clinical implications. Carcinogenesis 24:1897-1901.
21. Niklinsky J, Niklinska W, Laudanski J, Chyczewska E, Chyczewski XX. 2001. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 34(Suppl 2):S53-S58.
22. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. 2000. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954-5958.
23. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global Cancer Statistics, 2002. CA Cancer J Clin 55:74-108.
24. Sato M, Mori Y, Sakurada A, Fujimura S, Horii A. 1998. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Gen 103:96-101.
25. Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon C. 2004. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 10:2284-2288.
26. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. 2001. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61:4556-4560.
27. Toyooka S, Suzuki M, Maruyama R, Toyooka KO, Tsukuda K, Fukuyama Y, Iizasa T, Aoe M, Date H, Fujisawa T, Shimizu N, Gazdar AF. 2004. The relationship between aberrant methylation and survival in non-small-cell lung cancers. Br J Cancer 91:771-774.
28. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. 2002. DNA methylation analysis: A powerful new tool for lung cancer diagnosis. Oncogene 21:5450-5461.
29. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. 2003. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94:589-592.
30. Zhong Y, Delgado Y, Gomez J, Lee SW, Perez-Soler R. 2001. Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin Cancer Res 7:1683-1687.
31. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancer. Cancer Res 61:249-255.
32. Zochbauer-Muller S, Gazdar AF, Minna JD. 2002. Molecular pathogenesis of lung cancer. Annu Rev Physiol 64:681-708.